・Phase 2 data showed rapid increases in CD34+ stem cells, allowing same-day dosing and collection. ・Daratumumab-treated patients, who often struggle with mobilization, also achieved strong collection ...

- APHEXDA is the first innovation in stem cell mobilization for multiple myeloma to be approved in the U.S. in a decade - - One dosage of APHEXDA plus filgrastim enabled a majority of patients to ...

The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Stem cell transplantation is an important treatment method for ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved motixafortide combined with filgrastim for mobilization of hematopoietic stem cells into ...

The UK's first stem cell collection centre strictly dedicated to transplants has started welcoming donors. The Anthony Nolan Cell Collection Centre, based at Nottingham's Queen's Medical Centre (QMC), ...

All cell types found in the body are derived from stem cells. However, genetic mutations can impact the ability of stem cells to develop into fully functional cells. Also, as the body ages, the number ...

The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma. The FDA approved motixafortide ...

After 10 years of stagnation, a new FDA approval could help more cancer patients become eligible for stem cell transplants. Monday, Israeli drugmaker BioLineRx said the FDA approved motixafortide—also ...

SAN ANTONIO — South Texas is entering a new era in health care. BBG Advanced Therapies, a sister organization to South Texas Blood & Tissue has launched what it calls the world’s only mobile cell ...

Dose-intensive cyclophosphamide, etoposide, cisplatin reinduction for relapsed/refractory aggressive non-Hodgkin lymphoma (r/r-aNHL). The comparison of up-front autologous peripheral stem cell ...